Sanofi Starts Phase II Of Trials With Vaccine For Diarrhea Caused By Hospital Infection
This article was originally published in PharmAsia News
Executive Summary
Sanofi has begun Phase II trials in Japan with the clostridium difficile vaccine to prevent diarrhea caused by hospital infections.